Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Journey Medical Corp

Get SEC filing alerts via email and in your feed for Journey Medical Corp

DERM

Journey Medical Corp

About Journey Medical Corp

Journey Medical Corporation is a pharmaceutical company specializing in the development, marketing, and sale of FDA-approved dermatology products. Its portfolio includes treatments for rosacea, acne, hyperhidrosis, fungal infections, and skin conditions, primarily sold through specialty pharmacies and distributors in the U.S. The company leverages licensing, acquisitions, and proprietary technologies to innovate and expand its product offerings in the dermatology market.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Journey Medical Corp

1
1
Journey Medical Corp Journey Medical Corporation Reports 21% Revenue Growth to $15.96 Million in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
Journey Medical Corp Journey Medical Corporation Reports $61.9 Million Revenue for Fiscal Year 2025, Driven by Emrosi Launch

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Journey Medical Corp Journey Medical Corporation Reports 21% Revenue Growth in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Journey Medical Corp Journey Medical Corporation Reports Q2 2025 Financial Results with Revenue Increase and Reduced Net Losses

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Journey Medical Corp Journey Medical Corporation Reports Q1 2025 Financial Results with Revenue Growth and Improved Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Journey Medical Corp Journey Medical Corporation Reports 29% Revenue Decline and Increased Losses for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Journey Medical Corp Journey Medical Corporation Reports 58% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments